Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

352.579
-3.503-0.98%
Number of Gainers:10
Number of Losers:39
Number of Flat:10
PE:- -
High:355.477
Open:355.431
Low:350.722
Close:356.083
Volume:45.69M
Turnover:1.77B
Market Cap:845.63B
Float Cap:728.44B

Loading ...

Global New Material International - Expects Loss of RMB50 Mln–100 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 10

CH GENERAL EDU (02175) Appoints Tian Yan as Executive Director and Board Nomination Committee Member

Stock News
·
Aug 10

Six Investors in AUNTEA JENNY Signal Partial Unloading: Shares Dive 23%, Market Value Drops Below HK$10 Billion

Deep News
·
Aug 10

China General Education Group - MS. Zhang Zhonghua Resigns as Executive Director and Nomination Committee Member

THOMSON REUTERS
·
Aug 10

Kangqiao Service Says China Supreme Court Retrial Bid in Subsidiary Litigation Remains Pending

Reuters
·
Aug 10

Gold Jewelry Leads Consumer Recovery, AI-Driven Healthcare Continues Strong Momentum

Stock News
·
Aug 10

Linklogis Schedules Earnings Call to Discuss Interim Results

Reuters
·
Aug 10

Chaoju Eye Care Files HKEX Next-Day Return Disclosing Share Cancellation After Buyback

Reuters
·
Aug 10

Hong Kong Stocks Rise on Softer China Inflation; Auntea Jenny Falls 23%

MT Newswires Live
·
Aug 10

MORIMATSU INTL Proposes Up to HK$50 Million Share Buyback

Stock News
·
Aug 10

Morimatsu International Targets up to HK$ 50 Million in On-Market Share Buyback

Reuters
·
Aug 10

Morimatsu International - to Repurchase Shares up to HK$50 Mln in Open Market

THOMSON REUTERS
·
Aug 10

China Youran Dairy Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 10

Tea Chain Stock Plunges Nearly 24% After Releasing Fresh Voluntary Lock-Up Extension Notice

Deep News
·
Aug 10

Mid-Year Bonuses Announced at Trip.com Amidst Antitrust Penalty of 5.179 Billion Yuan

Deep News
·
Aug 10

Auntea Jenny Shareholders Extend Lock-Up Period to November; Shares Plunge 22%

MT Newswires Live
·
Aug 10

Keymed Biosciences (SEHK:2162) Hits A Phase III Milestone, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 10

Keymed Bio-B (02162) Announces Phase II Trial Success for CM512 in Chronic Sinusitis with Nasal Polyps

Stock News
·
Aug 10

Keymed Biosciences Says Phase II Trial of CM512 Meets Endpoints in Chronic Rhinosinusitis with Nasal Polyps

Reuters
·
Aug 10

Li Auto Files HKEX Next-Day Disclosure Return on Share Repurchase

Reuters
·
Aug 10